CSIMarket
 


Vyant Bio Inc   (VYNT)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

VYNT's EPS from Cont. Operations Growth by Quarter and Year

Vyant Bio Inc 's EPS from Cont. Operations results by quarter and year




VYNT EPS from Cont. Operations (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December -0.14 -0.85 -1.06 -0.01
III Quarter September -0.62 -0.15 -0.58 -2.38
II Quarter June -0.15 -0.14 -0.82 -0.01
I Quarter March -0.15 -2.31 -0.56 -0.09
FY   -1.06 -3.45 -3.02 -2.49



VYNT EPS from Cont. Operations fourth quarter 2022 Y/Y Growth Comment
Vyant Bio Inc in the fourth quarter 2022 recorded EPS loss from Cont. Operations of $ -0.14 .

According to the results reported in the fourth quarter 2022, Vyant Bio Inc achieved the best EPS from Cont. Operations growth in Medical Laboratories industry. While Vyant Bio Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the fourth quarter 2022.




VYNT EPS from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Vyant Bio Inc 's fourth quarter 2022 EPS from Cont. Operations $ -0.14 VYNT's Income Statement
Vyant Bio Inc 's fourth quarter 2021 EPS from Cont. Operations $ -0.85 Quarterly VYNT's Income Statement
New: More VYNT's historic EPS from Cont. Operations Growth >>


VYNT EPS from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Vyant Bio Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


VYNT's IV. Quarter Q/Q EPS from Cont. Operations Comment
Despite the fact, that Vyant Bio Inc in the IV. Quarter 2022 showed EPS loss from Cont. Operations of $ -0.14 , some analyst said, that current results are slight up side compare to the -0.62 in the third quarter.

Within Medical Laboratories industry Vyant Bio Inc achieved highest sequential EPS from Cont. Operations growth. While Vyant Bio Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


VYNT's IV. Quarter Q/Q EPS from Cont. Operations Comment
Despite the fact, that Vyant Bio Inc in the IV. Quarter 2022 admitted EPS loss from Cont. Operations of $ -0.14 , it should be mentioned, that those numbers show improvement relative to the -0.62 in the third quarter.

Within Medical Laboratories industry Vyant Bio Inc achieved highest sequential EPS from Cont. Operations growth. While Vyant Bio Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Vyant Bio Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
Cumulative EPS from Cont. Operations 12 Months Ending $ -1.06 $ -1.77 $ -1.30 $ -1.29 $ -3.45
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment


Vyant Bio Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment


Vyant Bio Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Medical Laboratories Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
VYNT's EPS from Cont. Operations Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for VYNT's Competitors
EPS from Cont. Operations Growth for Vyant Bio Inc 's Suppliers
EPS from Cont. Operations Growth for VYNT's Customers

You may also want to know
VYNT's Annual Growth Rates VYNT's Profitability Ratios VYNT's Asset Turnover Ratio VYNT's Dividend Growth
VYNT's Roe VYNT's Valuation Ratios VYNT's Financial Strength Ratios VYNT's Dividend Payout Ratio
VYNT's Roa VYNT's Inventory Turnover Ratio VYNT's Growth Rates VYNT's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Dec 31 2022
Encompass Health Corporation-2.60%$ -2.599 
Inmode Ltd -3.45%$ -3.448 
Vanda Pharmaceuticals Inc -4.54%$ -4.543 
Amedisys Inc -6.60%$ -6.603 
Iradimed Corporation-6.71%$ -6.706 
Vascular Biogenics Ltd -7.44%$ -7.437 
Eton Pharmaceuticals Inc -8.34%$ -8.343 
Lemaitre Vascular Inc -9.47%$ -9.470 
Amgen Inc -10.28%$ -10.281 
Polypid Ltd -10.53%$ -10.526 
Alcon inc -11.69%$ -11.688 
Bristol myers Squibb Company-12.06%$ -12.060 
Intuitive Surgical Inc -13.05%$ -13.054 
Acadia Healthcare Company Inc -13.87%$ -13.872 
Steris Plc-13.89%$ -13.889 
Stryker Corp-14.98%$ -14.980 
Envista Holdings Corporation-15.28%$ -15.279 
Pharming Group N v -16.00%$ -16.000 
Qiagen N v -17.33%$ -17.333 
Uniqure N v -18.15%$ -18.153 
Universal Health Services Inc -19.04%$ -19.040 
Merck and Co Inc -19.65%$ -19.652 
Chemed Corporation-21.29%$ -21.292 
Atrion Corporation-21.89%$ -21.886 
Orgenesis Inc -22.47%$ -22.472 
Integer Holdings Corporation-24.16%$ -24.155 
Baxter International Inc -24.70%$ -24.703 
Integrated Biopharma Inc-25.00%$ -25.000 
Becton Dickinson And Company-25.65%$ -25.652 
Syneos Health Inc -26.32%$ -26.321 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com